Aller au contenu principal
Profil bibliographique

Pooja Takhar

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

7Publications signalées
68Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Tuberous Sclerosis Complex ResearchPI3K/AKT/mTOR signaling in cancerEpilepsy research and treatmentCannabis and Cannabinoid ResearchRenal cell carcinoma treatment

Les publications récentes

Accès ouvert 2026 article OpenAlex

Co-Creation of the EpiCom Clinical Trial: Bringing the Tuberous Sclerosis Complex Patient Community, Healthcare Professionals, and the Pharmaceutical Industry Together

Lisa Moore-Ramdin, Agnies M. van Eeghen, Joanne Stevens, Pooja Takhar et autres

BACKGROUND: [EU], 100 mg/mL oral solution) on TAND, including behavioral outcomes, in participants with TSC-associated seizures. EpiCom was designed in collaboration with the TSC community including patients, caregivers, and healthcare professionals (HCPs), to incorporate stakeholder perspectives into study design and execution. OBJECTIVE: …

it, nl, us, gb (code pays fourni par la source)

0 citations Patient
Accès ouvert 2025 article OpenAlex

mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node

Laura Mantoan Ritter, Nicholas M. P. Annear, Emma L. Baple, Leila Y. Ben-Chaabane et autres

Mechanistic target of rapamycin (mTOR) is a highly conserved serine/threonine kinase that regulates key cellular processes including cell growth, autophagy and metabolism. Hyperactivation of the mTOR pathway causes a group of rare and ultrarare genetic diseases. mTOR pathway diseases have diverse clinical …

gb, be, us (code pays fourni par la source)

11 citations Orphanet Journal of Rare Diseases
Accès ouvert 2025 article OpenAlex

Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial

Renuka Dias, Kristian Brock, Kun Hu, Rajat Gupta et autres

Introduction Wolfram syndrome ( WFS1- Spectrum Disorder) is an ultra-rare monogenic form of progressive neurodegeneration and diabetes mellitus. In common with most rare diseases, there are no therapies to slow or stop disease progression. Sodium valproate, an anticonvulsant with neuroprotective properties, is …

gb, fr, au, es, pl, nl (code pays fourni par la source)

7 citations BMJ Open
Accès ouvert 2023 article OpenAlex

Fluid Optimisation in Emergency Laparotomy (FLO-ELA) Trial: study protocol for a multi-centre randomised trial of cardiac output-guided fluid therapy compared to usual care in patients undergoing major emergency gastrointestinal surgery

Mark Edwards, Gordon Forbes, Neil Walker, Dion Morton et autres

INTRODUCTION: Postoperative morbidity and mortality in patients undergoing major emergency gastrointestinal surgery are a major burden on healthcare systems. Optimal management of perioperative intravenous fluids may reduce mortality rates and improve outcomes from surgery. Previous small trials of cardiac-output guided haemodynamic therapy …

gb (code pays fourni par la source)

11 citations Trials
Accès ouvert 2023 article OpenAlex

Shared decision-making and the caregiver experience in tuberous sclerosis complex: results from a UK survey

Hanna Skrobanski, Kishan Vyas, Sally Bowditch, Lena Hubig et autres

BACKGROUND: Tuberous sclerosis complex (TSC) is a rare genetic condition commonly accompanied by neurological and neuropsychological disorders, resulting in a high burden of illness for individuals and a substantial impact on their caregivers. Due to the diversity and complexity of clinical manifestations, …

gb, us, it, fr (code pays fourni par la source)

11 citations Orphanet Journal of Rare Diseases
Accès ouvert 2023 article OpenAlex

The Burden of Caring for Individuals with Tuberous Sclerosis Complex (TSC) Who Experience Epileptic Seizures: A Descriptive UK Survey

Hanna Skrobanski, Kishan Vyas, Sally Bowditch, Lena Hubig et autres

INTRODUCTION: Tuberous sclerosis complex (TSC) is a rare multisystem genetic condition characterised by benign tumours; prevalent manifestations include epilepsy and neuropsychiatric disorders. This study examined the burden of TSC for primary caregivers and families, exploring the impact of characteristics such as seizures. …

gb, us (code pays fourni par la source)

20 citations PharmacoEconomics - Open
Accès ouvert 2022 article OpenAlex

Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatments

Marie Monaghan, Pooja Takhar, Luke Langlands, Markus Knuf et autres

Tuberous Sclerosis Complex (TSC) is a genetic condition which leads to a loss of inhibition of cellular growth. Facial angiofibromas (FAs) are hamartomatous growths associated with TSC that appear as multiple small, erythematous papules on the skin of the face and may …

gb (code pays fourni par la source)

8 citations Frontiers in Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.